Myelodysplastic syndrome (MDS) is a rare disease of the blood, occurring in just four out of every 1 million children. This rare blood disorder keeps the body from properly producing blood cells and producing enough of them. MDS develops in the bone marrow, the soft, spongy center of the long bones that produces the three major blood cells. With this disease, the blood cells lose their ability to mature and function properly.
MDS Treatment at Dana-Farber/Boston Children's
Children with MDS are treated through the Bone Marrow Failure and Myelodysplastic Syndrome Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, one of the nation's most experienced, multidisciplinary teams at diagnosing and treating pediatric MDS. Dana-Farber/Boston Children's is the only pediatric center in the U.S. that has been awarded the MDS Centers of Excellence award by the MDS Foundation.
Find in-depth information about myelodysplastic syndrome (MDS) on the Dana-Farber/Boston Children's website, including:
- How is MDS in children diagnosed?
- What are MDS treatment options?
- What is the latest research on MDS?